Form 4: SANUWAVE Health Executive VP Acquires Stock Options

David Timothy Wern, Executive VP of Sales at SANUWAVE Health, Inc., was granted stock options to purchase 50,000 shares of common stock.

Summary

• On January 8, 2025, David Timothy Wern, Executive VP of Sales at SANUWAVE Health, Inc., acquired stock options.
• The options grant him the right to buy 50,000 shares of SANUWAVE Health's common stock at an exercise price of $24.81 per share.
• The options vest in equal installments over a period of ten years, on each quarterly anniversary of the grant date.
• The options expire on January 8, 2035.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine executive compensation disclosure. The vesting period is long, which could be seen as a positive for long-term commitment.

Positives

• The grant of stock options to a key executive aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock options are a common form of executive compensation in the healthcare industry, used to incentivize performance and align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages across various industries, including healthcare.
• The vesting schedule of ten years is longer than some industry standards, which often range from three to five years.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the executive to improve company performance.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates